advertisement

---

Herrero-Vanrell R 16

Showing records 1 to 16 | Display all abstracts from Herrero-Vanrell R

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Brugnera M
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Ana González-Cela-Casamayor M; Rodrigo MJ
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Vicario-de-la-Torre M
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Brugnera M
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
González-Cela-Casamayor MA; González-Fernández FM
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Munuera I; Martínez-Rincón T
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Ferraboschi I
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Prats-Lluís C
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Andrés-Guerrero V; Nicoli S
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Villacampa P; García-Feijoó J
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Sissa C
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Pablo LE
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Pescina S; Herrero-Vanrell R
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Bravo-Osuna I; García-Martín E
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Bravo-Osuna I
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Herrero-Vanrell R
Drug Delivery 2025; 32: 2484277

---